Clinical trial EMBER-2
EMBER-2 : A phase 1, open-label, preoperative window study evaluating the biological effects of LY3484356 in post-menopausal women with stage I-III estrogen receptor-positive, HER2-negative breast cancer
Cancers | |
---|---|
Organ | Breast |
Trial status | Trial closed |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 1 |
Academic trial | Non |
Sponsor | Lilly |
EudraCT Identifier | 2020-002810-42 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04647487 |
Last update |